Clinical Trials in New York

Showing 19281-19300 of 22,668 trials

ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial

NCT00378612

ACROSS-Cypher® is a prospective, multi-center, open label, single arm study of the Cypher® sirolimus eluting coronary stent in native total coronary occlusion revascularization. The primary endpoint is binary angiographic restenosis at 6 months. The TOSCA-1 trial will be used as the historical control. The hypothesis is that compared with TOSCA-1 patients who were treated with the heparin-coated Palmaz Schatz stent, treatment with the Cypher® sirolimus eluting coronary stent will result in a \>50% relative reduction in 6 month restenosis within the treated segment of the target vessel.

Coronary Occlusions

Sunil Rao200 participantsStarted Jun 2005

La Jolla, California, United States • La Jolla, California, United States • Washington D.C., District of Columbia, United States +13 more locations

COMPLETEDPhase 1< 1 mile

Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer

NCT00516243

This randomized phase I trial studies the side effects and best dose of defined green tea catechin extract in treating women with hormone receptor-negative stage I-III breast cancer. Green tea extract contains ingredients that may prevent or slow the growth of breast cancer.

Estrogen Receptor-negative Breast CancerProgesterone Receptor-negative Breast CancerStage I Breast Cancer+3 more

National Cancer Institute (NCI)40 participantsStarted Jul 2007

New York, New York, United States • New York, New York, United States • Houston, Texas, United States +1 more locations

ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial

Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer

Find Trials by Condition in New York

A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

Comparative Study of Three NNRTI-Sparing HAART Regimens

Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

Valproic Acid in Treating Patients With Kaposi's Sarcoma

Randomized Comparison Angioplasty Outcomes at Hospitals With and Without On-site Cardiac Surgery

Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)

Conversion to Monotherapy Study With Keppra XR for Partial Seizures

Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures

Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male Volunteers

The Fibrin Patch Soft Tissue Study

Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis

Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease

Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis

Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer

Study of Adalimumab in Patients With Axial Spondyloarthritis

Evaluation of Corneal Epithelial Thickness Mapping

A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive

Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS)